CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...
US FDA clears Minghui Pharma’s IND application to begin global phase ? trials of MHB018A, a subcutaneous single-domain IGF-1R antibody, in thyroid eye disease: Shanghai Tuesday, ...
Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis: Washington Tuesday, December 16, 2025, 15:00 Hrs [IST] Vanda Pharmaceuticals Inc., (Van ...
Gujarat Kidney and Super Speciality, a regional healthcare company located in Gujarat, announced that its initial public offering (IPO) for subscription from Monday, 22nd December, 2025, and closes on ...
Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor: Hong Kong Tuesday, December 16, 2025, 14:3 ...
Global pharma major Lupin Limited (Lupin) announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). These ...
Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD: Melbourne, Australia Tuesday, December 16, 2025, 14:00 ...
DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing: Our Bureau, Bengaluru Tuesday, December 16, 2025, 13:50 Hrs [IST] Dnyaan ...
Hanahealth by DSS Imagetech takes GERI time-lapse incubator pan India: Our Bureau, Mumbai Tuesday, December 16, 2025, 13:40 Hrs [IST] Reiterating its commitment to revolutionising ...
IMA Kurukshetra hosts special session on drugs and cosmetics act: Our Bureau, Chennai Tuesday, December 16, 2025, 13:30 Hrs [IST] The Indian Medical Association (IMA) Kurukshetra ...
Bioretec’s RemeOs DrillPin receives US FDA Breakthrough Device Designation: Finland Tuesday, December 16, 2025, 13:00 Hrs [IST] Bioretec Oy (Bioretec), a pioneer in biodegradabl ...
GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe: Athens, Greece Tuesday, December 16, ...